Gene Therapy
The impact of CAR-T therapy on the myeloma treatment landscape, patient selection for CAR-T & the evolving role of autoSCT
The introduction of CAR-T therapy has revolutionized the myeloma treatment landscape, offering a promising therapeutic approach for patients with relapsed/refractory…
Date: 15th March 2024
Addressing the importance of lymphodepletion, factors contributing to ICAHT & the cost effectiveness of CAR-T therapy
Although CAR-T cells have revolutionized the treatment of hematological malignancies, there are several important factors that must be addressed regarding…
Date: 29th February 2024
Updates with the use of CAR-T therapy in ALL: ongoing challenges, strategies to overcome resistance & future outlooks
The treatment landscape of acute lymphoblastic leukemia (ALL) has transformed with the introduction of novel immunotherapeutic agents, including CAR-T cells…
Date: 22nd February 2024
Key updates in thalassemia at ASH 2023: gene therapies, ongoing trials & the value of precision medicine
In the last decade, the treatment landscape of thalassemia has been transformed with the introduction of novel therapies. With several…
Date: 31st January 2024
Unanswered questions regarding the sequencing of BCMA therapies, the prognostic value of CTCs & the growing role of quadruplets
The treatment and management of patients with multiple myeloma is continually evolving, giving rise to novel prognostic tools and therapeutic…
Date: 18th January 2024
Key updates in sickle cell disease at ASH 2023: disease biology, ongoing trials & the growing role of gene therapy
In recent years, the treatment landscape of sickle cell disease (SCD) has been revolutionized with the introduction of novel agents,…
Date: 12th January 2024
iwNHL 2023 Session V: Expanding the CAR platform in NHL
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 15th December 2023
iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials
The biennial International Workshop on Chronic Lymphocytic LeukemiaTM (iwCLL 2023) was held recently in Boston, MA, and brought together experts who…
Date: 7th December 2023
Unmet needs in AL amyloidosis, novel treatment strategies being explored, and the role of CHIP
In recent years, there have been promising therapeutic advances in light chain (AL) amyloidosis, however, several unmet needs remain in…
Date: 24th November 2023
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 3rd November 2023
iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
The 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts…
Date: 20th October 2023
Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL
The treatment and management of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains a major unmet need, and in recent…
Date: 23rd August 2023
